News & Highlights

Awards, appointments, grants, publications, and other updates from the Falls Informatics Group.

2026 4
Publication
2026 · Expert Opinion on Drug Discovery

Targeting KRAS Mutations in Non-Small Cell Lung Cancer

Samudrala, Bruggemann, Falls, and Mahajan review cutting-edge computational and experimental approaches for targeting driver KRAS mutations in NSCLC, integrating multiscale drug discovery with translational validation strategies.

View Publication →
Publication
2026 · Journal of Cheminformatics

Optimal Glioma Therapeutic Candidates via the CANDO Platform

Xu, Hu, Mangione, Van Norden, Elefteriou, Falls, and Samudrala apply the CANDO multiscale drug discovery platform to identify and prioritize therapeutic candidates for glioma, demonstrating improved benchmarking performance across approved drug recovery metrics.

View Publication →
Publication
2026 · BMC Pharmacology & Toxicology

BPA-Elicited Osteoarthritis Mechanisms and Novel Therapeutic Candidates

Xu, Jiang, Zhang, Falls, Samudrala et al. use network toxicology and molecular docking to decipher how bisphenol A drives osteoarthritis, identifying key hub targets and applying CANDO to generate novel therapeutic candidates including glucosamine, celecoxib, and ibuprofen.

View Publication →
Publication
2026 · bioRxiv [Preprint]

Novel Therapeutics for Schizophrenia via the CANDO Platform

Hu, Elefteriou, Falls, and Samudrala apply a multitarget computational approach using CANDO to uncover novel therapeutic candidates for schizophrenia, leveraging proteome-wide interaction signatures to identify repurposing opportunities beyond current antipsychotic classes.

View Publication →
2025 7
Grant
2025 · NCATS / CTSA

UB Awarded $29.2M CTSA Renewal

The University at Buffalo received a renewal of its NIH/NCATS Clinical and Translational Science Award (UL1 TR001412), totaling $29,204,726 over six years. Dr. Falls contributes biomedical informatics expertise to the award's research infrastructure and training cores.

View Funding →
Appointment
2025 · University at Buffalo

Affiliated Faculty — UB Institute for AI & Data Science

Dr. Falls was appointed as Affiliated Faculty in the University at Buffalo Institute for Artificial Intelligence and Data Science, reflecting the group's growing engagement with machine learning methodologies for biomedical discovery.

Appointment
2025 · Roswell Park Comprehensive Cancer Center

Adjunct Research Assistant Professor, Roswell Park

Dr. Falls was appointed as Adjunct Research Assistant Professor at Roswell Park Comprehensive Cancer Center, formalizing a collaborative relationship supporting oncology informatics research in KRAS-mutant cancers and computational drug discovery.

Service
2025 · AMIA

AMIA 2026 Scientific Program Committee

Dr. Falls was selected to serve on the American Medical Informatics Association (AMIA) 2026 Annual Symposium Scientific Program Committee, contributing to peer review and program development for one of the premier biomedical informatics conferences.

Publication
April 2025 · Journal of Studies on Alcohol and Drugs

Predictors of Rapid vs. Longer-Term OUD Development

Falls et al. identify clinical and social predictors of opioid use disorder onset timing among patients entering treatment for alcohol use disorder, drawing on New York State Medicaid and OASAS data across three waves of the opioid epidemic.

View Publication →
Publication
2025 · Bioinformatics

Robust Benchmarking Strategies for Drug Discovery Platforms

Van Norden, Mangione, Falls, and Samudrala present a framework for rigorous and generalizable benchmarking of computational drug discovery platforms, with direct application to the CANDO system and implications for the broader field.

View Publication →
Publication
2025 · Journal of the American Pharmacists Association

Prescribing Disparities in Opioid Dependence Treatment by Social Determinants

Lu, Su, Falls et al. examine disparities in opioid dependence drug prescribing among patients with alcohol and opioid use disorders in New York State, stratified by race, geography, and social determinant factors from 2005 to 2018.

View Publication →
2024 4
Award
2024 · Sinsheimer Foundation

Dr. Falls Named Sinsheimer Scholar

Dr. Falls was honored with the prestigious Sinsheimer Scholar Award from the Alexandrine and Alexander L. Sinsheimer Fund, recognizing outstanding early-career promise in biomedical research. The $60,000 award supports his computational drug discovery program.

View Funding →
Appointment
2024 · University at Buffalo

Affiliated Faculty — Clinical & Research Institute on Addictions

Dr. Falls was appointed as Affiliated Faculty at the UB Clinical and Research Institute on Addictions (CRIA), deepening the group's collaborative ties with addiction science researchers and strengthening the translational impact of its EHR and prescribing analytics work.

Publication
2024 · Communications Biology

APOBEC3-Mediated C-to-U RNA Editing in Human Disease

Van Norden, Falls, Mandloi et al. characterize the disease implications of APOBEC3-driven C-to-U RNA editing events across the human transcriptome, revealing broad relevance for disease variant interpretation and cancer biology in this Nature Portfolio journal.

View Publication →
Publication
2024 · Substance Abuse and Rehabilitation

OUD Incidence Across Three Waves of the Opioid Epidemic

Falls et al. track the incidence, timing, and social correlates of opioid use disorder development among New York State patients seeking treatment for alcohol use disorder, documenting how patterns shifted across the prescription, heroin, and synthetic opioid waves.

View Publication →
2023 4
Publication
January 2023 · International Journal of Molecular Sciences

KRAS-Targeted Drug Combinations Validated in Non-Small Cell Lung Cancer

Bruggemann, Falls, Mangione et al. apply multiscale CANDO analysis to identify and validate synergistic drug combinations targeting driver KRAS mutations in NSCLC — one of the most treatment-resistant cancer subtypes — providing computational and experimental evidence for several candidate regimens.

View Publication →
Publication
2023 · Clinical Microbiology Reviews

Comprehensive Review of Antiviral Approaches Against Influenza

Kumari, Falls et al. deliver a wide-ranging review of antiviral strategies targeting influenza A and B, covering approved therapies, resistance mechanisms, and emerging computational and structure-based approaches to next-generation antiviral discovery.

View Publication →
Publication
2023 · Journal of Biomedical Informatics

NY State Alcohol Use Disorder Cohort — Linked Administrative Data

Lu, Jette, Falls et al. describe the construction and validation of a large linked cohort of New York State patients with alcohol use disorder, merging two statewide administrative data sources to enable population-scale clinical informatics research.

View Publication →
Publication
2023 · Frontiers in Pharmacology

Holistic Small Molecule Characterization via Biological Networks

Mangione, Falls, and Samudrala present a network-based approach for characterizing small molecule effects across heterogeneous biological networks, advancing the methodological foundation of the CANDO platform's multi-scale drug interaction modeling.

View Publication →
2022 5
Appointment
2022 · University at Buffalo

Dr. Falls Joins UB as Assistant Professor of Biomedical Informatics

Following his NLM T15 postdoctoral training, Dr. Zackary Falls was appointed as Assistant Professor in the Department of Biomedical Informatics at the Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, where he established the Falls Informatics Group.

Grant
2022 · NIH / NIDA

NIDA K01 Awarded for Polypharmacy & Adverse Drug Reactions Research

Dr. Falls was awarded a NIDA K01 Mentored Research Scientist Career Development Award ($1,046,435, 2022–2027) to investigate polypharmacy-induced adverse drug reactions in patients with substance use disorders using a translational bioinformatics approach.

View Funding →
Grant
2022 · NIH / NLM

NLM T15 BRIGHT Training Grant Awarded

The Department of Biomedical Informatics received a renewal of the NLM T15 BRIGHT training grant ($1,997,145, 2022–2027), supporting graduate and postdoctoral training in biomedical informatics. Dr. Falls serves as Co-Investigator and mentor.

View Funding →
Publication
2022 · Frontiers in Pharmacology

Optimal COVID-19 Therapeutic Candidates via the CANDO Platform

Mangione, Falls, and Samudrala apply the CANDO platform to systematically identify repurposed therapeutic candidates against SARS-CoV-2 from the complete approved drug library, demonstrating the platform's rapid-response capability for emerging pathogens.

View Publication →
Publication
2022 · Journal of General Internal Medicine

Opioid & Benzodiazepine Co-Prescribing Trends in Alcohol Use Disorder

Jacobs, Tober, Falls et al. document longitudinal trends in concurrent opioid, benzodiazepine, and dual co-prescribing among adults with alcohol use disorder in New York State, revealing significant shifts with major clinical safety implications.

View Publication →
2021 3
Publication
2021 · Frontiers in Chemistry

Accurate HIV-1 Protease Inhibitor Binding Prediction via CANDOCK

Falls, Fine, Chopra, and Samudrala demonstrate accurate, proteome-scale prediction of HIV-1 protease inhibitor binding using the CANDOCK fragment-based docking algorithm, validating the approach against known inhibitor co-crystal structures.

View Publication →
Publication
2021 · Pharmaceuticals

Proteomic-Scale Deep Learning for Drug Design

Overhoff, Falls, Mangione, and Samudrala introduce a deep learning framework trained across thousands of protein–ligand complexes for structure-based drug design at proteome scale, extending the CANDO platform's AI-guided design capabilities.

View Publication →
Publication
2021 · Nature Communications

Protein Mimetic Abrogates Mutant p53 Aggregation

Palanikumar, Falls et al. demonstrate that a protein mimetic amyloid inhibitor potently disrupts cancer-associated mutant p53 aggregation and restores tumor suppressor function — a major oncology finding published in Nature Communications.

View Publication →
2020 3
Award
2017 · NIH / NLM

NLM T15 Informatics Postdoctoral Fellowship

Dr. Falls was awarded an NLM T15 Informatics Training Fellowship at the Jacobs School of Medicine and Biomedical Sciences, UB (2017–2020), supporting his postdoctoral training in clinical and translational bioinformatics that led directly to his faculty appointment.

Publication
2020 · Drug Discovery Today

"Shotgun Drug Repurposing" Featured in School News

Mangione, Falls, Melendy et al. publish "Shotgun drug repurposing biotechnology to tackle epidemics and pandemics" in Drug Discovery Today, outlining how proteome-wide CANDO screening can rapidly identify therapeutic candidates for emerging infectious disease outbreaks. The paper was featured in UB School of Medicine news.

View Publication →
Publication
2020 · Journal of Chemical Information and Modeling

cando.py Open Source Software Released

Mangione, Falls, Chopra, and Samudrala publish cando.py, an open-source Python library providing a complete, reproducible interface to the CANDO drug discovery platform for large-scale drug–protein–disease data analytics.

View Publication →